VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.2997
-0.0117 (-3.76%)
Dec 5, 2025, 4:00 PM EST - Market closed
VolitionRx Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for VolitionRx stock ranges from a low of $1.50 to a high of $5.00. The average analyst price target of $3.17 forecasts a 957.72% increase in the stock price over the next year.
Price Target: $3.17 (+957.72%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VolitionRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,568.34% | Dec 4, 2025 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,568.34% | Nov 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $1.5 | Strong Buy | Maintains | $2.5 → $1.5 | +400.50% | Nov 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,568.34% | Nov 17, 2025 |
Financial Forecast
Revenue This Year
1.92M
from 1.23M
Increased by 55.33%
Revenue Next Year
11.38M
from 1.92M
Increased by 493.79%
EPS This Year
-0.22
from -0.31
EPS Next Year
-0.11
from -0.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.3M | 30.7M | ||||
| Avg | 1.9M | 11.4M | ||||
| Low | 1.5M | 2.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 82.9% | 1,503.7% | ||||
| Avg | 55.3% | 493.8% | ||||
| Low | 19.2% | 42.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.21 | 0.09 | ||||
| Avg | -0.22 | -0.11 | ||||
| Low | -0.25 | -0.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.